For some people, simply putting on pants can be excruciatingly painful. New policy will put pain relief out of reach for many ...
An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, ...
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, ...
In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time ...
The American Diabetes Association has issued two explanations, two reviews and an apology over its June convention. A Friday ...
This week on the “The Readout LOUD” podcast, we remember our beloved colleague Helen Branswell, who died last week. We speak with colleagues, family, and public health leaders about her work and her ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results